Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Pancreatic Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01397019
What this trial is testing

Chemotherapy for Patients With Locally Advanced Pancreatic Cancer (LAPC) With Additional Chemo-radiotherapy (CRT) for Patients With Borderline Resectable Tumours

Who this might be right for
Pancreatic Cancer
Per Pfeiffer 56
Early research (Phase 1)Study completedNCT01286987
What this trial is testing

Study of Talazoparib, a PARP Inhibitor, in Patients With Advanced or Recurrent Solid Tumors

Who this might be right for
Advanced or Recurrent Solid TumorsBreast NeoplasmsOvarian Cancer, Epithelial+4 more
Pfizer 113
Early research (Phase 1)Study completedNCT02791334
What this trial is testing

Anti-PD-L1 Checkpoint Antibody (LY3300054) Alone and in Combination in Participants With Advanced Refractory Solid Tumors

Who this might be right for
Solid TumorMicrosatellite Instability-High (MSI-H) Solid TumorsCutaneous Melanoma+2 more
Eli Lilly and Company 164
Early research (Phase 1)Not Yet RecruitingNCT07624214
What this trial is testing

Study of LT-010391 in Participants With KRAS G12D-Mutant Solid Tumors

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)Colorectal Cancer (CRC)Pancreatic Ductal Adenocarcinoma (PDAC)+1 more
Leadingtac Pharmaceutical (Shaoxing) Co., Ltd. 198
Testing effectiveness (Phase 2)UnknownNCT00346281
What this trial is testing

32P BioSiliconTM in Addition to Gemcitabine in Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
pSiMedica Limited 15
Not applicableLooking for participantsNCT05298722
What this trial is testing

Prediction of Surgical Resectability After FOLFIRINOX Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Cancer: the Role of Diffusion Weighted Magnetic Resonance Imaging, Radiomics and Liquid Biopsy (PeRFormanCe Trial)

Who this might be right for
Pancreatic Cancer
University Hospital, Ghent 45
Large-scale testing (Phase 3)Looking for participantsNCT07235930
What this trial is testing

Firstline Sequential AG and mFOLFOX Combined With Serplulimab and Bevacizumab Versus AG Chemotherapy Alone in Advanced Pancreatic Cancer

Who this might be right for
Non-Resectable Pancreas Carcinoma
Zhejiang Cancer Hospital 292
Testing effectiveness (Phase 2)UnknownNCT01867892
What this trial is testing

A Phase II Study of Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
National Health Research Institutes, Taiwan 86
Testing effectiveness (Phase 2)Study completedNCT00810719
What this trial is testing

Gemcitabine and Erlotinib in Treating Patients With Metastatic or Recurrent Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
University of California, Davis 30
Testing effectiveness (Phase 2)Study completedNCT00219557
What this trial is testing

AG-013736 In Combination With Gemcitabine Versus Gemcitabine Alone For Patients With Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Neoplasms
Pfizer 111
Testing effectiveness (Phase 2)Looking for participantsNCT06051695
What this trial is testing

Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression

Who this might be right for
Solid Tumor, AdultColorectal CancerNSCLC+17 more
A2 Biotherapeutics Inc. 474
Early research (Phase 1)UnknownNCT02950064
What this trial is testing

Determine the Safety of BTP-114 for Treatment in Patients With Advanced Solid Tumors With BRCA Mutations

Who this might be right for
Pancreatic NeoplasmsOvarian NeoplasmsBreast Neoplasms+1 more
Placon Therapeutics 95
Early research (Phase 1)Study completedNCT02077933
What this trial is testing

Study of Safety and Efficacy of Alpelisib With Everolimus or Alpelisib With Everolimus and Exemestane in Advanced Breast Cancer Patients, Renal Cell Cancer and Pancreatic Tumors

Who this might be right for
NeoplasmsBreast NeoplasmsKidney Neoplasms+1 more
Novartis Pharmaceuticals 79
Early research (Phase 1)Study completedNCT00789763
What this trial is testing

Phase I-II to Evaluate Efficacy/Safety of Sorafenib+Gemcitabine+Radiotherapy in Locally Advanced Pancreatic Carcinoma

Who this might be right for
Pancreatic Cancer
Grupo Espanol Multidisciplinario del Cancer Digestivo 12
Testing effectiveness (Phase 2)Looking for participantsNCT07040228
What this trial is testing

A Phase Ib/II Clinical Study of Regorafenib Combined With Toripalimab and Albumin-bound Paclitaxel for the Third-line Treatment of Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer Metastatic
Junjie Hang 23
Not applicableUnknownNCT04518800
What this trial is testing

PEG-rhG-CSF in Secondary Prevention of Nab-Paclitaxel Combined With S-1 in Advanced Pancreatic Cancer

Who this might be right for
PEG-rhG-CSFPancreatic Cancer
Chinese PLA General Hospital 20
Testing effectiveness (Phase 2)Looking for participantsNCT05086692
What this trial is testing

A Beta-only IL-2 ImmunoTherapY Study

Who this might be right for
Advanced Solid TumorUnresectable Solid TumorClear Cell Renal Cell Carcinoma+34 more
Medicenna Therapeutics, Inc. 115
Testing effectiveness (Phase 2)Study completedNCT00034827
What this trial is testing

Phase 2 Study of CI-1040 in Patients With Advanced Nonsmall-Cell Lung, Breast, Colon and Pancreatic Cancer

Who this might be right for
Colorectal NeoplasmsBreast NeoplasmsCarcinoma, Non-Small-Cell Lung+1 more
Pfizer 172
Not applicableActive Not RecruitingNCT04002479
What this trial is testing

Alpha Radiation Emitters Device for the Treatment of Advanced Pancreatic Cancer

Who this might be right for
Pancreatic CancerUnresectable Pancreatic CancerMetastatic Pancreatic Cancer+1 more
Alpha Tau Medical LTD. 37
Testing effectiveness (Phase 2)Ended earlyNCT01318642
What this trial is testing

Ganitumab in Locally Advanced Unresectable Adenocarcinoma of the Pancreas

Who this might be right for
Adenocarcinoma of the PancreasLocally AdvancedUnresectable
NantBioScience, Inc. 10
Next Page